[Federal Register Volume 84, Number 118 (Wednesday, June 19, 2019)]
[Notices]
[Page 28459]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12990]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-05-2019]


Foreign-Trade Zone (FTZ) 93--Raleigh/Durham, North Carolina; 
Authorization of Production Activity; GlaxoSmithKline, PLC 
(Pharmaceutical Products), Zebulon, North Carolina

    On February 13, 2019, GlaxoSmithKline, PLC, submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within FTZ 93, in Zebulon, North Carolina.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (84 FR 6128, February 26, 2019). On 
June 13, 2019, the applicant was notified of the FTZ Board's decision 
that no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
Section 400.14.

    Dated: June 13, 2019.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2019-12990 Filed 6-18-19; 8:45 am]
BILLING CODE 3510-DS-P